Academic Journal
Q1Journal of Inherited Metabolic Disease
About Journal of Inherited Metabolic Disease
About Journal of Inherited Metabolic Disease
Journal of Inherited Metabolic Disease is a peer-reviewed scholarly journal published by Springer Netherlands (Netherlands). It focuses on Q1. Publication coverage spans 1978-2026.
Key indicators: ISSN 0141-8955, 1573-2665; H-index 131.
Understanding This Journal's Metrics
Journal metrics help researchers assess fit, but they must be interpreted in context:
- H-index (131): Exceptionally high — 131 articles have each been cited at least 131 times. This indicates deep, sustained influence in the field.
Publishing in Journal of Inherited Metabolic Disease
An established venue in its field. The journal welcomes solid, well-executed research. Ensure your manuscript fits the stated scope and follows author guidelines carefully.
- Scope fit: Confirm your research aligns with Q1. Off-scope manuscripts are typically desk-rejected quickly.
- Author guidelines: Follow formatting, reference style, and article-type requirements exactly — non-compliant manuscripts may be returned without review.
Is This Journal Right for Your Paper?
- Audience match: Will the journal's readers cite and build on your findings?
- Timeline: Higher-tier journals mean longer review and higher rejection risk. Balance prestige against your schedule.
- Indexing: Confirm indexing in Web of Science, Scopus, and PubMed (if biomedical) meets your institutional requirements.
- Open access needs: Check funder mandates and whether the journal offers compliant OA options.
Frequently Asked Questions
What is the ISSN of Journal of Inherited Metabolic Disease?
0141-8955, 1573-2665.
Who publishes Journal of Inherited Metabolic Disease?
Springer Netherlands.
What are Journal of Inherited Metabolic Disease's metrics?
H-index 131.
Is Journal of Inherited Metabolic Disease peer-reviewed?
Yes — it is a peer-reviewed scholarly journal indexed in major academic databases.
Source-backed journal facts
Topics in published research
Metabolism and Genetic Disorders; Lysosomal Storage Disorders Research; Mitochondrial Function and Pathology; Amino Acid Enzymes and Metabolism; Biochemical and Molecular Research; Folate and B Vitamins Research.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Reported open-access list prices
3,470.00 USD; 2,890.00 EUR; 2,310.00 GBP
APC list prices reported by OpenAlex, which obtains this information from DOAJ. Confirm current charges, taxes, waivers and eligibility with the publisher; this is not a fee quotation.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Tailored Amino Acid Treatment for Pediatric Patients With Mitochondrial Aminoacyl‐ tRNA Synthetase Deficiencies
I. J. J. Muffels, G. Kok, Z. Tang, L. S. Medeiros et al.
2026-11 · DOI: 10.1002/jimd.70254Revisiting Inherited Metabolic Diseases ( IMDs ) Through the Lens of Selective Autophagy
Marianna Maddaluno, Laura Cinque, Viviana Cetrangolo, Chiara De Leonibus et al.
2026-11 · DOI: 10.1002/jimd.70259Dichloroacetate Improves Animal Survival, Growth, Neuromuscular Activity, Mitochondrial Stress and Physiology, and Elevated Lactate in C. elegans pdha‐1 and dld‐1 RNAi Models of Pyruvate Dehydrogenase Complex Deficiency ( PDCD )
Cristina Remes, Neal D. Mathew, Victoria Miranda, Suraiya Haroon et al.
2026-11 · DOI: 10.1002/jimd.70257Obituary for Prof. Marcello Giovanni
Enrica Riva, Giacomo Biasucci, Elvira Verduci
2026-11 · DOI: 10.1002/jimd.70258Consensus Guidelines for Diagnosis and Management of Pyruvate Dehydrogenase Complex Deficiency
Nandaki Keshavan, Julia Neugebauer, Marcello Bellusci, Enrico Bertini et al.
2026-11 · DOI: 10.1002/jimd.70226Issue Information
2026-11 · DOI: 10.1002/jimd.70206Congenital Disorders of Glycosylation ( CDG ): State of the Art in 2026
Patryk Lipiński, Jaak Jaeken
2026-11 · DOI: 10.1002/jimd.70256Essential Oral Single Nutritional Therapy Products for Inherited Metabolic Diseases: Evidence and Consensus Assessment Using a Modified Delphi Method
Nina N. Stolwijk, Bart M. F. Penninx, Annet M. Bosch, Mirjam Langeveld et al.
2026-11 · DOI: 10.1002/jimd.70252L‐Carnitine Prevents Lipopolysaccharide‐Induced Inflammatory Response, Microglia Activation and Neuronal Damage in Cerebral Cortex, as Well as Neuromotor Development Delay in Neonatal Glutaryl‐ CoA Dehydrogenase Deficient ( Gcdh −/− ) Mice
Ediandra Tissot Castro, Ângela Zanatta, Rafael Teixeira Ribeiro, Diorlon Nunes Machado et al.
2026-09 · DOI: 10.1002/jimd.70253Sarcopenia in Pediatric Intoxication Type Inborn Errors of Metabolism: A Frequent and Underrecognized Condition
Silvio Veraldi, Maria Sole Basso, Giovanna Soglia, Riccardo Cirelli et al.
2026-09 · DOI: 10.1002/jimd.70250International Guideline on the Diagnosis, Treatment, and Monitoring of Long‐Chain Fatty Acid Oxidation Disorders ( LC ‐ FAOD )
Sarah C. Grünert, Kaustuv Bhattacharya, Daniela Karall, Mirjam Langeveld et al.
2026-09 · DOI: 10.1002/jimd.70251Distinct Urea Cycle Dysfunction Profiles Differentiate Acute Metabolic Decompensation in TMEM70 and MT ‐ ATP6 ‐Related Mitochondrial ATP Synthase Defects
Barbara Siri, Diego Martinelli, Rosalba Carrozzo, Sara Boenzi et al.
2026-09 · DOI: 10.1002/jimd.70244Results From a Phase 2, Open‐Label Study Evaluating the Safety, Tolerability, and Effect on Ataxia of GLM101 in Three Adult Patients With PMM2 ‐ CDG
Mercedes Serrano, Florencia Epifani, Rose Marino, Peter McWilliams et al.
2026-09 · DOI: 10.1002/jimd.70240Treatment of Fatty Acid Oxidation Disorders Today: Emerging Personalized Treatment Strategies
U. Spiekerkoetter, J. Vockley
2026-09 · DOI: 10.1002/jimd.70255Genome Editing for Glycogen Storage Diseases
Troy von Beck, Raymond Wang, Dwight Koeberl
2026-09 · DOI: 10.1002/jimd.70249Revisiting Enzyme Replacement Therapy for Aspartylglucosaminuria: Truncated Phosphotransferase Enhances Mannose‐6‐Phosphorylation and Cellular Uptake of Aspartylglucosaminidase
Antje Banning, Lidia Reznikova, Adla Murad, Ritva Tikkanen et al.
2026-09 · DOI: 10.1002/jimd.70248Longitudinal Assessment of Cognitive Development in 23 Patients With Mucopolysaccharidosis ( MPS ) Type II : Results of up to 14 Years of Follow‐Up
J. (Julia) Holdorp, M. E. (Michelle) Kruijshaar, A. A. M. (Audrey) Vollebregt, A. B. (Andre) Rietman et al.
2026-09 · DOI: 10.1002/jimd.70246Mitochondrial CLPP in Health and Disease: Mechanisms, Therapeutic Duality and Emerging Opportunities
Lea Isermann, Aleksandra Trifunovic
2026-09 · DOI: 10.1002/jimd.70247Reviews
Community Reviews
Version History
October 9, 2026 at 7:33 pm
September 25, 2026